Acute renal failure associated with the use of tenofovir combined with atazanavir in patients with HIV infection;Insuficiencia renal aguda asociada al uso de tenofovir combinado con atazanavir en pacientes con infección por el VIH

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 26, Issue 5, 2008, Pages 316-317

  Vallecillo Sánchez, Gabriel ^a   Guelar Grimberg, Ana ^a   González Mena, Alicia ^a   Knobel Freud, Hernando ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ATAZANAVIR; CREATININE; EMTRICITABINE; LAMIVUDINE; RITONAVIR; TENOFOVIR;

ADULT; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; KIDNEY FUNCTION; LETTER; MALE; TREATMENT DURATION;

EID: 44149096306     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1157/13120423     Document Type: Letter

References (10)

1. H. Izzedine C. Isnard-Bagnis J.S. Hulot D. Vittecoq A. Cheng C.K. Jais Renal safety of tenofovir in HIV treatment-experienced patients AIDS 18 2004 1074 1076
2. H. Izzedine J.S. Hulot D. Vittecoq J.E. Gallant S. Staszewski V. Launay-Vacher Longterm renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study Nephrol Dial Transplant 20 2005 743 746
3. A.E. Zimmermann T. Pizzoferrato J. Bedford A. Morris R. Hoffman Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions Clin Infect Dis 42 2006 283 290
4. J.E. Gallant Parish Ma J.C. Keruly R.D. Moore Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment Clin Infect Dis 40 2005 1194 1198
5. S. Mauss F. Berger G. Schmutz Antiretroviral therapy with tenofovir is associated with mild renal dysfunction AIDS 19 2005 93 95
6. A.M. Taburet C. Piketty C. Chazallon I. Vincent L. Gerard V. Calvez Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients Antimicrob Agents Chemother 48 2004 2091 2096
7. S. Kaul K. Bassi B. Damle J. Xie J. Gale B. Kearney Pharmacokinetic (PK) evaluation of the combination of atazanavir (ATV), enteric coated didanosine (ddI-EC), and tenofovir disoproxil fumarate (TDF) for a oncedaily antiretroviral regimen ICAAC, sept 14-17 2003 Chicago (abstract A-1616)
8. V. D’Agat G.B. Appel HIV infection and the kidney J Am Soc Nephrol 8 1997 138 152
9. M. Harris R. Joy N. Zalunardo R. Werb B. Yip R. Hogg Predictors of creatinine (Cr) increase and drug discontinuation in patients receiving tenofovir DF (TDF) 8th Congress on Drug Therapy in HIV Infection (HIV8) Glasgow. November 12-16 2006 Abstract PL13.2
10. R. Jones J. Stebbing M. Nelson G. Moyle M. Bower S. Mandalia Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study J Acquir Immune Defic Syndr 37 2004 1489 1495